One potential cellular mechanism by which mid-differentiated ERMS cells can drive tumor growth is to undergo de-differentiation and become classically defined myf5-GFP+/mylz2-mcherry-negative self-renewing TPCs. Here, MYF5 is linked to neoplasm.